Lexicon Pharmaceuticals Pfizer: Which Stock Is Best Buy 2026
In 2026, investors face a choice between a nimble biotech player and a global pharma titan. This guide compares Lexic...
Using emergency funds to pay off credit card debt can be tempting but may leave you vulnerable. Weigh the pros and cons to make the best decision.
23,601 articlesIn 2026, investors face a choice between a nimble biotech player and a global pharma titan. This guide compares Lexic...
A landmark listed on the NYSE signals bigger access to capital and greater scrutiny for cannabis companies. Learn how...
A high-stakes moment for semiconductor supply and AI chip strategy has investors watching ASML. This analysis explain...
Nvidia CEO Jensen Huang lays out a sweeping forecast: hundreds of thousands of skilled tradespeople will be key to fu...
Looking for steady income and growth over the next ten years? These three dividend stocks hold next decade potential ...
The GRID fund has surged about 23% in 2026, outpacing the traditional utilities ETF XLU as AI-enabled grid modernizat...
NovaCore Technologies enters the second half of 2026 with a multi-year backlog, AI revenue momentum, and cloud growth...
Palantir has volatile days, but one wall street analyst believes the stock could double within a year. This article b...
The semiconductor rally has investors eyeing Intel ahead of its July 23 report. This guide breaks down whether you sh...
A tight group of U.S.-listed power chip stocks built around silicon carbide and GaN technologies are rallying as elec...
Wall Street traders weigh a contrarian opportunity as Pfizer and Gilead trade below fair value amid rising bearish se...
Memory chips power today’s data centers, AI accelerators, and personal devices. This guide breaks down the case for S...